Caryn Lerman: Saul Priceman will be the founding director of the new KSOM/USC Norris Center for Cancer Cellular Immunotherapy Research
Caryn Lerman, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on LinkedIn:
“We are delighted to announce that Dr. Saul Priceman will join USC Norris and the Department of Medicine in the Keck School of Medicine of the University of Southern California on September 1, 2024. A renowned tumor immunologist and national leader in cellular immunotherapy, Dr. Priceman will be the founding director of the new KSOM/USC Norris Center for Cancer Cellular Immunotherapy Research. Dr. Priceman will work closely with leaders of our growing research, GMP, and clinical teams to lead and prioritize translational immunotherapy programs that bring new promising treatments to people with cancer.
Over the last decade, Dr. Priceman’s research has centered on the development of engineered anti-cancer immunity including Chimeric Antigen Receptor (CAR)-based T cell immunotherapy, with a focus on metastatic disease in prostate, pancreas, breast, and ovarian cancers. He has successfully translated his innovative research from bench to bedside into phase 1 clinical trials for many of these diseases. Dr. Priceman’s laboratory focuses on novel combinatorial and gene engineering strategies to overcome challenges facing solid cancers, with strong team science that has been continuously funded by the National Institute of Health, the Department of Defense, the California Institute for Regenerative Medicine, and other agencies.
Please join us in welcoming Dr. Priceman to the Trojan Family!”
Source: Caryn Lerman/LinkedIn